144 related articles for article (PubMed ID: 16256400)
1. [Hereditary predispositions to gynaecological cancers].
Coupier I; Pujol P
Gynecol Obstet Fertil; 2005 Nov; 33(11):851-6. PubMed ID: 16256400
[TBL] [Abstract][Full Text] [Related]
2. Inherited cancer predisposition syndromes in Greece.
Apessos A; Papadopoulou E; Belogianni I; Baratsis S; Triantafillidis JK; Kosmidis P; Karydas E; Briasoulis E; Pisiotis C; Papazisis K; Nasioulas G
Anticancer Res; 2008; 28(2B):1341-7. PubMed ID: 18505076
[TBL] [Abstract][Full Text] [Related]
3. Cancer genetics and reproduction.
Hanson H; Hodgson S
Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):3-18. PubMed ID: 19864186
[TBL] [Abstract][Full Text] [Related]
4. Inherited risk of women's cancers: what's changed for the practicing physician?
Frank TS; Critchfield GC
Clin Obstet Gynecol; 2002 Sep; 45(3):671-83; discussion 730-2. PubMed ID: 12370607
[No Abstract] [Full Text] [Related]
5. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.
Quehenberger F; Vasen HF; van Houwelingen HC
J Med Genet; 2005 Jun; 42(6):491-6. PubMed ID: 15937084
[TBL] [Abstract][Full Text] [Related]
6. Hereditary cancer syndromes.
Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
[TBL] [Abstract][Full Text] [Related]
7. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
8. The genetic prediction of risk for gynecologic cancers.
Randall LM; Pothuri B
Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
[TBL] [Abstract][Full Text] [Related]
9. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
10. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
11. Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors.
Pedroni M; Di Gregorio C; Cortesi L; Reggiani Bonetti L; Magnani G; Simone ML; Medici V; Priore Oliva C; Marino M; Ponz de Leon M
Tech Coloproctol; 2014 Mar; 18(3):285-9. PubMed ID: 23695190
[TBL] [Abstract][Full Text] [Related]
12. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
Lynch HT; Casey MJ; Snyder CL; Bewtra C; Lynch JF; Butts M; Godwin AK
Mol Oncol; 2009 Apr; 3(2):97-137. PubMed ID: 19383374
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of hereditary ovarian cancer.
Boyd J
Oncology (Williston Park); 1998 Mar; 12(3):399-406; discussion 409-10, 413. PubMed ID: 9534190
[TBL] [Abstract][Full Text] [Related]
14. Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
Pokharel HP; Hacker NF; Andrews L
Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):633-638. PubMed ID: 27530527
[TBL] [Abstract][Full Text] [Related]
15. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
16. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
17. [Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome)].
Gómez A; Salguero G; García H; Aristizábal F; Gutiérrez O; Angel LA; Padrón J; Martínez C; Martínez H; Malaver O; Barvo R; Giraldo A
Biomedica; 2005 Sep; 25(3):315-24. PubMed ID: 16276679
[TBL] [Abstract][Full Text] [Related]
18. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
